Health
Study reveals new mutations that make cancer resistant to KRAS-targeted therapies – News-Medical.Net
A gene called KRAS is one of the most commonly mutated genes in all human cancers, and targeted drugs that inhibit the protein expressed by mutated KRAS have shown…
A gene called KRAS is one of the most commonly mutated genes in all human cancers, and targeted drugs that inhibit the protein expressed by mutated KRAS have shown promising results in clinical trials, with potential approvals by the U.S. Food and Drug Administration anticipated later this year.
Unfortunately, cancer cells often develop additional mutations that make them resistant to such targeted drugs, resulting in disease relapse. Now researchers led by a team at Massachusetts General Hospital…
-
General23 hours agoFrom jackaroo to ‘Golden Tonsils’ radio titan: the life and career of John Laws
-
General14 hours agoAFL gives teams finishing 10th chance to win premiership through wildcard round in finals
-
General10 hours agoPrincess Anne remembers Porepunkah police officers in wreath-laying ceremony in Melbourne
-
General22 hours agoWhen the lights go out … so does everything else